McArthur, Julie H <br/><br/>
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.  [electronic resource] 

 -  The American journal of tropical medicine and hygiene  Nov 2008 
 - 678-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1476-1645 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Viral--blood<br/>Dengue Virus--immunology<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Liver--drug effects<br/>Male<br/>Middle Aged<br/>Neutralization Tests<br/>Placebos<br/>Vaccines, Attenuated--adverse effects<br/>Viral Vaccines--adverse effects